Plant-made pharmaceuticals: An overview and update
Loading...
No Access Until
Permanent Link(s)
Other Titles
Authors
Abstract
There are advantages to plant-made pharmaceuticals: overall economy of production, lack of need for major capital investment (e.g. in fermentation bioreactors), ease and economy of scale-up, lack of risk of contamination with human pathogens, etc. However, significant markets for plant-made proteins failed to develop. Concerns about contamination of existing crops with compounds from the corresponding transgenic crop would be moot if pharmaceuticals, for example, were synthesized with “vehicle” plants that so far have not been developed for food or feed such as tobacco and related Nicotiana species.
Journal / Series
Volume & Issue
Description
Sponsorship
Date Issued
2005
Publisher
NABC
Keywords
Agricultural biotechnology; environment, human health; GMO, genetic engineering, pharming; plant based vaccines; medicinals; regulation; liability, patents; stewardship
Location
Effective Date
Expiration Date
Sector
Employer
Union
Union Local
NAICS
Number of Workers
Committee Chair
Committee Co-Chair
Committee Member
Degree Discipline
Degree Name
Degree Level
Related Version
Related DOI
Related To
Related Part
Based on Related Item
Has Other Format(s)
Part of Related Item
Related To
Related Publication(s)
Link(s) to Related Publication(s)
References
Link(s) to Reference(s)
Previously Published As
Government Document
ISBN
ISMN
ISSN
Other Identifiers
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International
Types
book chapter